{"transactions":[{"id":721199,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T20:33:41.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1905,"price":11.15,"value":21240.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026."}],"balance_after":203227,"source":{"system":"sec-edgar","filing":"0001997032-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000006/primarydocument.xml","form_type":"4"}},{"id":858315,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:31:04.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":58672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":58672,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":58672},"source":{"system":"sec-edgar","filing":"0001997032-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000004/primarydocument.xml","form_type":"4"}},{"id":858314,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:04.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":13.3054,"value":14635.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":201322,"source":{"system":"sec-edgar","filing":"0001997032-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000004/primarydocument.xml","form_type":"4"}},{"id":858313,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:04.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":40100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":202422,"source":{"system":"sec-edgar","filing":"0001997032-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000004/primarydocument.xml","form_type":"4"}},{"id":867069,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:10:24.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1441,"price":13.6638,"value":19689.5358,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":162322,"source":{"system":"sec-edgar","filing":"0001997032-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000003/primarydocument.xml","form_type":"4"}},{"id":943195,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-08T21:22:06.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":1,"price":10.99,"value":10.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025."}],"balance_after":163763,"source":{"system":"sec-edgar","filing":"0001997032-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000001/primarydocument.xml","form_type":"5"}},{"id":1008126,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T21:09:14.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":752,"price":12.82,"value":9640.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":163762,"source":{"system":"sec-edgar","filing":"0001997032-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703225000004/primarydocument.xml","form_type":"4"}},{"id":1097824,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:20:52.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":833,"price":15.13,"value":12603.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":164514,"source":{"system":"sec-edgar","filing":"0001562180-25-005189","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005189/primarydocument.xml","form_type":"4"}},{"id":1219529,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-06T21:41:41.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":81499,"price":18.19,"value":1482466.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates."}],"balance_after":81499,"derivative":{"exercise_price":18.19,"exercise_date":"2026-03-04","expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":81499},"source":{"system":"sec-edgar","filing":"0001562180-25-002161","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002161/primarydocument.xml","form_type":"4"}},{"id":1219528,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:41:41.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":54975,"price":18.19,"value":999995.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":163681,"source":{"system":"sec-edgar","filing":"0001562180-25-002161","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002161/primarydocument.xml","form_type":"4"}},{"id":1235735,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:23.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":225,"price":20.549,"value":4623.525,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 27, 2025, the reporting person sold 225 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":108706,"source":{"system":"sec-edgar","filing":"0001562180-25-001914","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001914/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235734,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:23.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":1162,"price":19.9219,"value":23149.2478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 1,162 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":108931,"source":{"system":"sec-edgar","filing":"0001562180-25-001914","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001914/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235729,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:27:51.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":225,"price":20.549,"value":4623.525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 225 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":108706,"source":{"system":"sec-edgar","filing":"0001562180-25-001835","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001835/primarydocument.xml","form_type":"4"}},{"id":1235728,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:27:51.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":1162,"price":19.9219,"value":23149.2478,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, the reporting person sold 1,162 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":108931,"source":{"system":"sec-edgar","filing":"0001562180-25-001835","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001835/primarydocument.xml","form_type":"4"}},{"id":1377133,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-04T21:34:52.000Z","date":"2024-10-31","kind":"sale","planned":false,"acquired":false,"shares":810,"price":15.7922,"value":12791.682,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.48 USD to $16.01 USD; the price reported above reflects the weighted average sale price."}],"balance_after":110093,"source":{"system":"sec-edgar","filing":"0001562180-24-007517","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024007517/primarydocument.xml","form_type":"4"}},{"id":1439618,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-06T20:16:26.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1736,"price":12.24,"value":21248.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2024 through June 30, 2024.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2024."}],"balance_after":110903,"source":{"system":"sec-edgar","filing":"0001562180-24-006038","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024006038/primarydocument.xml","form_type":"4"}},{"id":1609993,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-29T21:36:30.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":109443,"price":16.3,"value":1783920.9,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 109,443 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":109443,"derivative":{"exercise_price":16.3,"exercise_date":"2025-02-27","expiration_date":"2034-02-26","underlying":"Ordinary Shares","underlying_shares":109443},"source":{"system":"sec-edgar","filing":"0001562180-24-001987","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001987/primarydocument.xml","form_type":"4"}},{"id":1609992,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-29T21:36:30.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":71574,"price":16.3,"value":1166656.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":109167,"source":{"system":"sec-edgar","filing":"0001562180-24-001987","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001987/primarydocument.xml","form_type":"4"}},{"id":1749791,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-03T20:08:31.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":57604,"price":13.3,"value":766133.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options will vest in equal parts on the first, second, third and fourth anniversary of the grant date."}],"balance_after":57604,"derivative":{"exercise_price":13.3,"exercise_date":"2024-10-31","expiration_date":"2033-10-30","underlying":"Ordinary Shares","underlying_shares":57604},"source":{"system":"sec-edgar","filing":"0001562180-23-007549","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007549/primarydocument.xml","form_type":"4"}},{"id":1749790,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2023-11-03T20:08:31.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":37593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":37593,"source":{"system":"sec-edgar","filing":"0001562180-23-007549","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007549/primarydocument.xml","form_type":"4"}}]}